The present invention provides a method of treating Type I diabetes by administration of an effective amount of a glucagon-like peptide 1 or an analogue of glucagon-like peptide 1 either alone or in conjunction with a regimen of insulin administration.

 
Web www.patentalert.com

< Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue

< Glucagon-like peptide-1 analogs

> Glucagon-like peptide-2 and its therapeutic use

> Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
~ 00234